TrialCancer chemotherapy and pharmacology2019

Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study.

Naveed Shaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.